Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C19H24N2O4.2ClH |
| Molecular Weight | 417.327 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.Cl.COC1=C(C=CC=C1)N2CCN(CC(O)C3=CC(O)=C(O)C=C3)CC2
InChI
InChIKey=PZQYPHRFNJMIQO-UHFFFAOYSA-N
InChI=1S/C19H24N2O4.2ClH/c1-25-19-5-3-2-4-15(19)21-10-8-20(9-11-21)13-18(24)14-6-7-16(22)17(23)12-14;;/h2-7,12,18,22-24H,8-11,13H2,1H3;2*1H
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C19H24N2O4 |
| Molecular Weight | 344.4049 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Pipratecol is substituted thienoimidazole. It is the H+/K(+)-ATPase inhibitor. In a high concentration of 10(-4) g/ml, pipratecol increased the amplitude of isolated guinea-pig atrial contractions while decreased the rate. But, in a low concentration of 10(-8) g/ml, the drug decrease the amplitude and increased the rate slightly. The effects of adrenaline and noradrenaline were suppressed by the preceding addition of pipratecol, while that of isoproterenol was scarcely. The effect of pipratecol on atrial contractions was hardly influenced by reserpine with which the animal had been pretreated 24 hours before the sacrifice of animal. The augmentative effect of nicotine on atrial contractions was slightly suppressed by the preceding addition of pipratecol. From these results, it was assumed that pipratecol has some affinity with the adrenergic receptor of atria. As a peripheral vasodilator it has been used in conjunction with raubasine in the treatment of cerebrovascular disorders. Pipratecol was used as antiulcerative agent also.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Substituted thieno[3,4-d]imidazoles, a novel group of H+/K(+)-ATPase inhibitors. Differentiation of their inhibition characteristics from those of omeprazole. | 1990-10-23 |
|
| [Effect of raubasine and pipratecol on platelet aggregation and on the platelet release reaction]. | 1980-02-29 |
|
| Effect of a Raubasine-Pipratecol association (Isosarpan) on the sympathetic control of cerebral circulation. | 1979-02 |
|
| [Pharmacological study of pipratecol (JP 711) and of a pharmaceutical combination raubasine-JP 711]. | 1969-11 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:17:34 GMT 2025
by
admin
on
Mon Mar 31 22:17:34 GMT 2025
|
| Record UNII |
QM4158R9RL
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
15622-04-5
Created by
admin on Mon Mar 31 22:17:34 GMT 2025 , Edited by admin on Mon Mar 31 22:17:34 GMT 2025
|
PRIMARY | |||
|
SUB03865MIG
Created by
admin on Mon Mar 31 22:17:34 GMT 2025 , Edited by admin on Mon Mar 31 22:17:34 GMT 2025
|
PRIMARY | |||
|
DTXSID20935401
Created by
admin on Mon Mar 31 22:17:34 GMT 2025 , Edited by admin on Mon Mar 31 22:17:34 GMT 2025
|
PRIMARY | |||
|
QM4158R9RL
Created by
admin on Mon Mar 31 22:17:34 GMT 2025 , Edited by admin on Mon Mar 31 22:17:34 GMT 2025
|
PRIMARY | |||
|
100000085292
Created by
admin on Mon Mar 31 22:17:34 GMT 2025 , Edited by admin on Mon Mar 31 22:17:34 GMT 2025
|
PRIMARY | |||
|
239-696-8
Created by
admin on Mon Mar 31 22:17:34 GMT 2025 , Edited by admin on Mon Mar 31 22:17:34 GMT 2025
|
PRIMARY | |||
|
3014901
Created by
admin on Mon Mar 31 22:17:34 GMT 2025 , Edited by admin on Mon Mar 31 22:17:34 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |